NCBI PubMed Central
open access
Urinary podocalyxin as an early biomarker for diabetic nephropathy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Role of Pentraxin-3 in Assessment of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus#427409
- Hyperuricemia and Diabetic Nephropathy#287446
- Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic Children#979245
- Relationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy#885177
- Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy#980447
Record · ID 395950
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive